Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Cerenome

Tracked across 2 events · 12 articles · First seen Jul 31, 2026 · Last active Sep 13, 2026

Sentiment
18
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Impact: Cerenome is the new corporate identity of MiNK Therapeutics, effective August 3, 2026. It will trade under the ticker CNSY and aims to integrate diagnostics, therapeutics, and AI to improve CNS cancer care, potentially enhancing its market position.
Jul 31, 2026 · 6 articles
2 25
Business
Cerenome, Inc. (Nasdaq: CNSY), a clinical-stage CNS oncology company, announced on September 10, 2026 that it entered into a financing agreement with 3i, LP for a senior secured facility of up to $20 million with…
Impact: Cerenome is the borrower and central party of the event, securing up to $20 million in non-dilutive capital that extends its cash runway into 2028 and funds CNSide commercialization.
Sep 10, 2026 · 6 articles
95 Cerenome entered financing agreement 3iCerenome Secures $20M 3i...
80 3i provided initial funding CerenomeCerenome Secures $20M 3i...
ERGEN INTELLIGENCE
Track Cerenome live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.